Labor Arbeiten Pipette

Support for SARS-CoV-2 diagnostics

The LabHive digital platform aims to provide necessary resources to diagnostic centres to enable more tests for SARS-CoV-2. Tobias Opialla from the MDC is one of 15 volunteers who has been involved in the project since the #WirvsVirus Hackathon organized by the German government.

An interdisciplinary team of 15 scientists, physicians, web developers, and security experts will use the digital platform LabHive to bundle testing capacities for SARS-CoV-2 and to compensate for bottlenecks in diagnostic centers. On LabHive qualified volunteers can provide their manpower, and research laboratories can offer reagents and equipment. Diagnostic centres have access to these services and can call on support if needed.

LabHive provides resources such as personnel, reagents or equipment that might otherwise remain unused.
Opialla
Dr. Tobias Opialla Wissenschaftler am MDC und Teamlead von LabHive.

"In many university or non-university research labs, the corona crisis has restricted scientific operations," says Dr. Tobias Opialla from the Berlin Institute for Medical Systems Biology (BIMSB), an institution of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC). "LabHive provides resources such as personnel, reagents or equipment that might otherwise remain unused." Like all participants, Opialla works voluntarily on the development and implementation of the platform.

The idea for this project was born during the #WirVsVirus-Hackathon of the German government and the project is currently funded by the German Federal Ministry of Education and Research. Their partner is the Björn Steiger Foundation.

An interdisciplinary team coordinates test capacities for SARS-CoV-2 using the LabHive digital platform.

Further Information

Press contacts

Dr. Tobias Opialla
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Berlin Institute for Medical Systems Biology (BIMSB)
Scientist at the Proteomics and Metabolomics Platform
+49 30 9406 1330
Tobias.Opialla@mdc-berlin.de

Christina Anders
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Editor, Communication Department
+49-30 9406 2118
christina.anders@mdc-berlin.de or presse@mdc-berlin.de

The Max Delbrück Center for Molecular Medicine (MDC)

 

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) was founded in Berlin in 1992. It is named for the German-American physicist Max Delbrück, who was awarded the 1969 Nobel Prize in Physiology and Medicine. The MDC's mission is to study molecular mechanisms in order to understand the origins of disease and thus be able to diagnose, prevent and fight it better and more effectively. In these efforts the MDC cooperates with the Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH ) as well as with national partners such as the German Center for Cardiovascular Research and numerous international research institutions. More than 1,600 staff and guests from nearly 60 countries work at the MDC, just under 1,300 of them in scientific research. The MDC is funded by the German Federal Ministry of Education and Research (90 percent) and the State of Berlin (10 percent), and is a member of the Helmholtz Association of German Research Centers. www.mdc-berlin.de